2-tert-butylhydroquinone has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, H; Dong, H; Gao, R; Jiang, Y; Kong, W; Liu, G; Mu, H; Shi, H; Su, J; Sun, X | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cucurbitaceae; Drugs, Chinese Herbal; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroquinones; Lung Neoplasms; Male; MAP Kinase Signaling System; MicroRNAs; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Saponins; Triterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2018 |